Back to Trades
Deliargyris Efthymios
Chief Medical OfficerCIK 0001751617
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
Across 1 filing between 2025, Deliargyris Efthymios, Chief Medical Officer, has disclosed $95.0K in transactions — all concentrated in Cytosorbents Corp (CTSO). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Aug 8 | CTSO Cytosorbents Corp | Deliargyris Efthymios | Chief Medical Officer | Grant | $95.0K |
1 filing